Patents by Inventor Andrew Kalusa

Andrew Kalusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused heterocyclic compounds and their use
    Patent number: 9550764
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: January 24, 2017
    Assignee: The Institute of Cancer Research: Royal Cancer Hospital
    Inventors: Keith Jones, Matthew David Cheeseman, Spyridon Linardopoulos, Amir Faisal, Olivier Remi Barbeau, Andrew Kalusa
  • FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE
    Publication number: 20150232462
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
    Type: Application
    Filed: August 22, 2013
    Publication date: August 20, 2015
    Inventors: Keith Jones, Matthew David Cheeseman, Spyridon Linardopoulos, Amir Faisal, Olivier Remi Barbeau, Andrew Kalusa